Related Experiment Video
Updated: Jun 19, 2026

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
Published on: January 20, 2017
Modelling mitigation strategies for pandemic (H1N1) 2009
Marija Zivkovic Gojovic1, Beate Sander, David Fisman
1Toronto Health Economics and Technology Assessment Collaborative, University of Toronto, Research Institute of the Hospital for Sick Children, Toronto, ON. mgojovic@uhnres.utoronto.ca
Rapid vaccine deployment significantly reduces pandemic H1N1 attack rates. Early action and pre-existing immunity are key to controlling outbreaks, even with delayed vaccination or school closures.
Area of Science:
- Epidemiology
- Public Health Modeling
Background:
- The 2009 influenza A (H1N1) pandemic presented significant uncertainties for decision-makers.
- Simulation models are crucial for projecting mitigation strategy effectiveness, but results vary with assumptions.
Purpose of the Study:
- To develop and utilize a simulation model to evaluate H1N1 pandemic mitigation strategies.
- To identify public health response program features that minimize attack rates under various uncertainties.
Main Methods:
- A simulation model of the 2009 H1N1 pandemic was created using Ontario demographic and influenza data.
- Attack rates were projected under different vaccination, school closure, and antiviral strategies.
- Combinatorial uncertainty analysis assessed epidemiologic and program uncertainties.
Main Results:
- Vaccination delays over 30 days decreased effectiveness; however, 15%+ pre-existing immunity maintained low attack rates.
- School closures were effective early in outbreaks but less critical with early vaccine availability or strong immunity.
- Early vaccination proved disproportionately effective in reducing H1N1 attack rates.
Conclusions:
- Prompt action, particularly rapid vaccine deployment, is highly effective in mitigating pandemic H1N1.
- Findings are critical given the early 2009 H1N1 emergence in educational settings.
More Related Videos
08:10Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
Published on: January 15, 2020
10:11Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
Related Concept Videos
Infectious Diseases and Their Occurrence
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Steps in Outbreak Investigation